Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
The Biochemical Journal
|
June 21, 2001
Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells
M Kortylewski, P C Heinrich, M E Kauffmann, et al.
The Biochemical Journal
|
January 22, 2000
Cytoplasmic STAT proteins associate prior to activation
S Haan, M Kortylewski, I Behrmann, et al.
FEBS Letters
|
March 21, 2000
Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis
S Thiel, U Sommer, M Kortylewski, et al.
Oncogene
|
July 3, 1999
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
M Kortylewski, P C Heinrich, A Mackiewicz, et al.
The Journal of Investigative Dermatology
|
July 10, 2001
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity
M Böhm, U Schulte, J O Funk, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
The Biochemical Journal
|
June 21, 2001
Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells
M Kortylewski, P C Heinrich, M E Kauffmann, et al.
The Biochemical Journal
|
January 22, 2000
Cytoplasmic STAT proteins associate prior to activation
S Haan, M Kortylewski, I Behrmann, et al.
FEBS Letters
|
March 21, 2000
Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis
S Thiel, U Sommer, M Kortylewski, et al.
Oncogene
|
July 3, 1999
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
M Kortylewski, P C Heinrich, A Mackiewicz, et al.
The Journal of Investigative Dermatology
|
July 10, 2001
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity
M Böhm, U Schulte, J O Funk, et al.
Page
of 1